4 results
Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral
oral therapy - Rivaroxaban ... reversal agent - VKA, UFH ... anticoagulant #selection #decisionaid ... #vte #anticoagulation ... #pharmacology
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
#anticoagulation ... #INR #heparin #LMWH ... Xarelto #apixaban #Eliquis ... #dabigatran #Pradaxa ... #management #pharmacology
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Kcentra) - Heparin/LMWH ... Protamine sulfate - Dabigatran ... ) - Apixaban (Eliquis ... Edoxaban (Lixiana), Rivaroxaban ... #doac #noac #pharmacology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Pathophysiology Anticoagulation ... the mainstay of VTE ... warfarin) for chronic anticoagulation ... #Pharmacology #Pathophysiology ... #UFH #DOAC #Dabigatran